Sign In
Buy ADAP
$0.0549
+0 (+0%)
At Close: Feb 20, 2026
Why Adaptimmune Therapeutics Stock Is Popping Today
03:27pm, Monday, 27'th Jun 2022
Buyout fever is sparking interest in the biotech's beaten-down shares today.
Finally Returning To Adaptimmune Therapeutics Ahead Of Anticipated BLA
06:35am, Sunday, 19'th Jun 2022
Adaptimmune Therapeutics is a cell therapy company using their TCR-engineered T cells to take on various tumor types. Their leading program is MAGE-A4 which contains afami-cel, a TCR-engineered T cell
Why Shares of Adaptimmune Therapeutics Rose 13.4% on Tuesday
05:03pm, Tuesday, 17'th May 2022
The clinical-stage biotech saw its shares rise after releasing preclinical data on two of its therapies.
Adaptimmune Therapeutics' (ADAP) CEO Adrian Rawcliffe on Q1 2022 Results - Earnings Call Transcript
01:57pm, Monday, 09'th May 2022
Adaptimmune Therapeutics plc (NASDAQ:ADAP ) Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Juli Miller – Head-Investor Relations Adrian Rawcliffe – Chief Executive Of
New Strong Sell Stocks for April 26th
09:02am, Tuesday, 26'th Apr 2022
ANIK, ALIM, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2022
New Strong Sell Stocks for April 22nd
10:32am, Friday, 22'nd Apr 2022
BBBY, CLGN, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2022
Why Adaptimmune Therapeutics, Agenus, and Sorrento Therapeutics Popped Today
03:43pm, Tuesday, 19'th Apr 2022
Regeneron's buyout of Checkpoint Pharmaceuticals is sparking a rally among clinical-stage cancer research companies today.
Why Adaptimmune Therapeutics Shares Dropped 14.7% on Monday
04:40pm, Monday, 11'th Apr 2022
Investors were not pleased that the company is preparing for a stock sale.
New Strong Sell Stocks for April 11th
12:48pm, Monday, 11'th Apr 2022
DDD, ADAP, and AKYA have been added to the Zacks Rank #5 (Strong Sell) List on April 11, 2022.
New Strong Sell Stocks for March 25th
09:02am, Friday, 25'th Mar 2022
DDD, ADAP, and ADV have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2022.
New Strong Sell Stocks for March 17th
12:12pm, Thursday, 17'th Mar 2022 Zacks Investment Research
DDD, ADAP, and AKYA have been added to the Zacks Rank #5 (Strong Sell) List on March 17, 2022.
New Strong Sell Stocks for March 17th
09:47am, Thursday, 17'th Mar 2022
DDD, ADAP, and AKYA have been added to the Zacks Rank #5 (Strong Sell) List on March 17, 2022.
Adaptimmune Therapeutics Plc''s (ADAP) CEO Adrian Rawcliffe On Q4 2021 Results - Earnings Call Transcript
04:16pm, Monday, 14'th Mar 2022 Seeking Alpha
Tenet Healthcare (THC) Up 55% in a Year: Is More Upside Left?
03:31pm, Monday, 14'th Mar 2022 Zacks Investment Research
Growing revenues, strong performances exhibited by segments, numerous acquisitions and sturdy financial standing continue to drive Tenet Healthcare (THC).
